on Applied DNA Sciences (NASDAQ:APDN )
Applied DNA Presents Linea IVT Platform at mRNA Summit
Applied DNA Sciences, Inc. (NASDAQ: APDN), known for PCR-based DNA technologies, will showcase its Linea IVT platform at the 3rd Annual mRNA Process Development & Manufacturing Summit in Boston. Representatives from LineaRx, a subsidiary of Applied DNA, will attend the event from September 17-19, 2024.
LineaRx will highlight the Linea™ IVT platform, which combines an enzymatically produced DNA template with a next-generation RNA polymerase. This technology promises faster mRNA production with reduced double-stranded RNA (dsRNA) contamination.
A seminar luncheon co-hosted with mRNA CDMO partner Kudo Biotechnology will provide proof-of-concept and case study data. The event will occur on September 19 at MassBio and will be available via webcast.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Applied DNA Sciences news